BRIM Biotechnology, Inc.
6885.TWO
Price:
$29.2
Market Cap:
$3.83B
BRIM Biotechnology, Inc., a clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases. The company's lead product candidate is BRM 421, a topical ophthalmic solution for patients with moderate-to-severe dry eye syndrome that has completed a phase 2 clinical trial in the United States. It is also developing BRM 423 to treat severe corneal damage, which is in phase 1 clinical trial; BRM 424 for the treatment of neurotrophic keratitis, which is in phase 1 clinical trial; and BRM 521 to relieve and repair tissue damage caused by osteoarthritis. The company was founded in 2013 and is based in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2022-06-24
Stock Exchange
TWO
Ticker
6885.TWO
PE Ratio
[-6.03]
ROE
[-11.90%]
Current Ratio
[5.18]
Dividend Yield
[0%]
Enterprise Value
[3.09B]
Dividend History
The ROE as of December 2025 (TTM) for BRIM Biotechnology, Inc. (6885.TWO) is -11.90%
According to BRIM Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is -11.90%. This represents a change of -1.17% compared to the average of -12.04% of the last 4 quarters.
BRIM Biotechnology, Inc. (6885.TWO) Historical ROE (quarterly & annually)
How has 6885.TWO ROE performed in the past?
The mean historical ROE of BRIM Biotechnology, Inc. over the last ten years is -29.10%. The current -11.90% ROE has changed -59.11% with respect to the historical average. Over the past ten years (40 quarters), 6885.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -30.39%.
Average
-29.10%
Median
-31.66%
Minimum
-39.62%
Maximum
-15.34%
BRIM Biotechnology, Inc. (6885.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of BRIM Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.89%
Maximum Annual ROE = -15.34%
Minimum Annual Increase = -61.28%
Minimum Annual ROE = -39.62%
| Year | ROE | Change |
|---|---|---|
| 2024 | -15.34% | -61.28% |
| 2023 | -39.62% | 32.13% |
| 2022 | -29.99% | 35.89% |
| 2021 | -22.07% | -33.80% |
| 2020 | -33.33% | -2.62% |
BRIM Biotechnology, Inc. (6885.TWO) Average ROE
How has 6885.TWO ROE performed in the past?
The current ROE of BRIM Biotechnology, Inc. (6885.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.32%
5-year avg
-28.07%
10-year avg
-29.10%
BRIM Biotechnology, Inc. (6885.TWO) ROE vs. Peers
How is 6885.TWO’s ROE compared to its peers?
BRIM Biotechnology, Inc.’s ROE is greater than Energenesis Biomedical CO.,LTD. (-25.31%), greater than Senhwa Biosciences, Inc. (-28.27%), greater than Formosa Pharmaceuticals, Inc. (-4.84%), greater than TWi Biotechnology, Inc. (-69.83%), greater than Medigen Biotechnology Corp. (-6.42%), less than Synbio Tech Inc. (13.55%), greater than UnicoCell Biomed Co., Ltd. (-12.58%), greater than AnnJi (-54.10%), less than Syngen Biotech Co.,Ltd. (13.01%), greater than Taiwan Bio Therapeutics Co., Ltd (-42.93%),
| Company | ROE | Market cap |
|---|---|---|
| -25.31% | $3.75B | |
| -28.27% | $3.64B | |
| -4.84% | $4.03B | |
| -69.83% | $1.81B | |
| -6.42% | $4.42B | |
| 13.55% | $3.11B | |
| -12.58% | $4.86B | |
| -54.10% | $4.99B | |
| 13.01% | $3.18B | |
| -42.93% | $2.31B |
Build a custom stock screener for BRIM Biotechnology, Inc. (6885.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BRIM Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BRIM Biotechnology, Inc. (6885.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BRIM Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is BRIM Biotechnology, Inc.'s ROE?
How is the ROE calculated for BRIM Biotechnology, Inc. (6885.TWO)?
What is the highest ROE for BRIM Biotechnology, Inc. (6885.TWO)?
What is the 3-year average ROE for BRIM Biotechnology, Inc. (6885.TWO)?
What is the 5-year average ROE for BRIM Biotechnology, Inc. (6885.TWO)?
How does the current ROE for BRIM Biotechnology, Inc. (6885.TWO) compare to its historical average?